# Effectiveness of the Q-HPV Vaccine 9-years Post Vaccination Among HIV Positive Adolescents

> **NCT05435209** · PHASE4 · COMPLETED · sponsor: **University of Washington** · enrollment: 158 (actual)

## Conditions studied

- HPV Infection
- HPV Vaccination

## Interventions

- **DRUG:** Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recombinant Vaccine

## Key facts

- **NCT ID:** NCT05435209
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-25
- **Primary completion:** 2023-10-31
- **Final completion:** 2023-10-31
- **Target enrollment:** 158 (ACTUAL)
- **Last updated:** 2023-11-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05435209

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05435209, "Effectiveness of the Q-HPV Vaccine 9-years Post Vaccination Among HIV Positive Adolescents". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05435209. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*